DTC Testing Survey Spotlights Acceptance and Concerns

A survey primarily using Scripps employees and Navigenics test offering shows that 50 percent of DTC genomics test takers have concerns, but over 80 percent want to know risks even of non-preventable diseases.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.